Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 23.08B | 23.10B | 23.05B | 22.15B | 19.94B | 18.36B |
Gross Profit | 11.28B | 11.20B | 10.76B | 9.33B | 8.54B | 8.68B |
EBITDA | 4.34B | 4.49B | 4.15B | 3.54B | 3.16B | 3.44B |
Net Income | 2.54B | 2.68B | 2.39B | 2.02B | 1.86B | 2.03B |
Balance Sheet | ||||||
Total Assets | 25.36B | 23.63B | 22.95B | 22.59B | 20.67B | 20.40B |
Cash, Cash Equivalents and Short-Term Investments | 269.80M | 210.40M | 276.80M | 198.80M | 165.70M | 226.60M |
Total Debt | 12.77B | 11.91B | 11.81B | 12.51B | 11.50B | 10.11B |
Total Liabilities | 20.96B | 19.58B | 19.24B | 19.49B | 18.23B | 16.79B |
Stockholders Equity | 4.40B | 4.05B | 3.72B | 3.10B | 2.44B | 3.61B |
Cash Flow | ||||||
Free Cash Flow | 2.15B | 2.08B | 2.63B | 1.28B | 1.87B | 3.10B |
Operating Cash Flow | 3.06B | 3.15B | 3.52B | 1.92B | 2.24B | 3.41B |
Investing Cash Flow | -1.17B | -1.20B | -1.04B | -1.61B | -476.40M | -322.40M |
Financing Cash Flow | -1.83B | -2.02B | -2.42B | -282.40M | -1.83B | -3.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $6.73B | 15.10 | 22.09% | ― | -1.01% | 50.58% | |
78 Outperform | $16.21B | 23.59 | 25.42% | 1.64% | 0.51% | 17.21% | |
72 Outperform | $91.74B | 36.54 | 62.43% | 0.84% | 0.31% | 2.66% | |
65 Neutral | $7.66B | 9.37 | 14.52% | 4.95% | 1.60% | -3.97% | |
64 Neutral | $30.65B | 40.24 | 0.31% | 2.12% | 4.55% | -130.25% | |
63 Neutral | $25.47B | 20.01 | 16.88% | 2.45% | -10.59% | -7.79% | |
61 Neutral | $10.07B | 6.27 | 0.59% | 3.01% | 2.91% | -45.05% |
On August 8, 2025, Sherwin-Williams Company and its subsidiaries amended their existing revolving credit agreement, extending the maturity date to August 8, 2030, and modifying certain financial terms. Additionally, Sherwin-Williams entered into a new 364-day senior unsecured delayed draw term loan credit agreement, providing a $750 million US dollar tranche and a €250 million Euro tranche, available for general corporate purposes. These financial arrangements aim to enhance the company’s liquidity and operational flexibility, potentially impacting its financial leverage and market positioning.
The most recent analyst rating on (SHW) stock is a Buy with a $370.00 price target. To see the full list of analyst forecasts on Sherwin-Williams Company stock, see the SHW Stock Forecast page.
On July 29, 2025, Sherwin-Williams Company announced the offering and sale of $1.5 billion in senior notes with varying maturity dates and interest rates. This financial move, involving major underwriters and trust companies, is part of the company’s strategic financial management to support its operations and growth plans.
The most recent analyst rating on (SHW) stock is a Buy with a $378.00 price target. To see the full list of analyst forecasts on Sherwin-Williams Company stock, see the SHW Stock Forecast page.